Cypherpunk reports first Zcash mining quarter, $9.9M revenue, as Leap reviews sirexatamab plan
Cypherpunk's new mining fleet produced 8,967 ZEC in six weeks while subsidiary Leap Therapeutics seeks financing or a partner to advance sirexatamab into Phase 3.
Cypherpunk Technologies Inc. (Nasdaq: CYPH) reported third-quarter 2026 results on November 16, 2026, covering the period ended September 30, 2026. The company said the launch of Cypherpunk Mining in August was transformative, enabling production of ZEC alongside purchases, and that in the first six weeks of operation the fleet earned 8,967.29 ZEC with 95% uptime, all added to treasury1. The company translated that Zcash flow into $9.9 million in recorded revenue, with the average fair value of mined ZEC above $1,100 and a hosting cost to mine one ZEC of approximately $1041.
The mining fleet was created through an August 17, 2026 acquisition from Moria Mining, LLC, an affiliate of Winklevoss Treasury Investments, LLC, of Bitmain Antminer Z15 Pro machines and related hosting agreements, for a purchase price of $33.33 million paid through issuance to WTI of a pre-funded warrant for 43,290,042 shares at $0.001 per share1. In September 2026 Cypherpunk Mining signed a letter of intent with Bitmain Technologies Delaware Limited for next-generation Zcash machines, with a purchase commitment of up to $30.0 million, including a $6.0 million refundable deposit, and delivery expected in mid-20271.
Including October mining results and recent open market purchases, Cypherpunk held 341,858.75 ZEC, about 2.01% of circulating supply, with a stated goal of reaching at least 5% over time1.
On the biotech side, subsidiary Leap Therapeutics said that following publication of the randomized Phase 2 DeFianCe study in Clinical Cancer Research in August 2026, receipt of Fast Track designation in May 2026, and FDA alignment on a registrational Phase 3 trial design in a DKK1-high 2L CRC population, Leap initiated a strategic process to identify the best path forward for sirexatamab and secure resources to advance it into Phase 31. That process may include independent financing or a strategic transaction such as a partnership, license, collaboration, sale or other business combination, though there is no assurance of any outcome and no set timetable1.
As of September 30, 2026, Cypherpunk held cash and cash equivalents of $56.0 million and ZEC treasury holdings valued at $470.1 million1.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.